General Information


We are a global medical technology company focused on the development and commercialization of our proprietary Hi-VNI Technology products that are used to treat patients of all ages suffering from respiratory distress. Our Hi-VNI Technology delivers noninvasive ventilatory support by providing heated, humidified and oxygenated air at a high velocity to patients through a comfortable small-bore nasal interface. Our Precision Flow systems, which use Hi-VNI Technology, are clinically validated alternatives to, and address many limitations of, the current standard of care for the treatment of respiratory distress in a hospital setting. As of September 30, 2018, more than 1.5 million patients have been treated with our Precision Flow systems, and we have a global installed base of over 12,000 capital units.

Employees: 298
Founded: 1999
Contact Information
Address 100 Domain Drive, Exeter, NH 03833, US
Phone Number (866) 410-9986
Web Address
View Prospectus: Vapotherm
Financial Information
Market Cap $234.2mil
Revenues $41.1 mil (last 12 months)
Net Income $-38.6 mil (last 12 months)
IPO Profile
Symbol VAPO
Exchange NYSE
Shares (millions): 4.0
Price range $14.00 - $14.00
Est. $ Volume $56.0 mil
Manager / Joint Managers BofA Merrill Lynch/ William Blair
CO-Managers Canaccord Genuity/ BTIG
Expected To Trade: 11/14/2018
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change